Eton Pharmaceuticals, Inc. ETON Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s total liabilities & equity?
- Eton Pharmaceuticals, Inc. (ETON) reported total liabilities & equity of $97.71M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s total liabilities & equity changed year-over-year?
- Eton Pharmaceuticals, Inc.'s total liabilities & equity increased by 16.3% year-over-year, from $84.03M to $97.71M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s total liabilities & equity has grown at a 28.5% compound annual growth rate (CAGR), from $26.32M to $92.11M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.